meglumine has been researched along with Neurofibromatosis 1 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bessou, P; Chateil, JF; Ducassou, S; Havez-Enjolras, M; Marsault, P; Menut, F | 1 |
Agnetti, V; Bianchini, E; Conti, M; Maninetti, MM; Parazzini, C; Rossi, LN; Scotti, G; Triulzi, F; Zanolini, C | 1 |
De Silva, M; McHugh, K; North, KN; Van Es, S | 1 |
3 other study(ies) available for meglumine and Neurofibromatosis 1
Article | Year |
---|---|
Diagnostic performance of an unenhanced MRI exam for tumor follow-up of the optic pathway gliomas in children.
Topics: Child; Child, Preschool; Contrast Media; Disease Progression; Female; Humans; Magnetic Resonance Imaging; Male; Meglumine; Neurofibromatosis 1; Optic Nerve Glioma; Organometallic Compounds; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity | 2019 |
Spontaneous involution of optic pathway lesions in neurofibromatosis type 1: serial contrast MR evaluation.
Topics: Adolescent; Child; Child, Preschool; Contrast Media; Cranial Nerve Neoplasms; Drug Combinations; Female; Follow-Up Studies; Gadolinium DTPA; Humans; Infant; Magnetic Resonance Imaging; Male; Meglumine; Neurofibromatosis 1; Optic Nerve; Optic Nerve Diseases; Organometallic Compounds; Pentetic Acid | 1995 |
MRI findings in children with neurofibromatosis type 1: a prospective study.
Topics: Brain; Brain Neoplasms; Child; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Neurofibromatosis 1; Organometallic Compounds; Pentetic Acid; Prospective Studies | 1996 |